Effect of smoking on global cognitive function in nondemented elderly

Neurology

Volumn 62, Issue 6, 2004, Pages 920-924

  Ott, A ^a   Andersen, K ^b   Dewey, M E ^c   Letenneur, L ^e   Brayne, C ^d   Copeland, J R M ^c   Dartigues, J F ^e   Kragh Sorensen, P ^b   Lobo, A ^f   Martinez Lage, J M ^g   Stijnen, T ^a   Hofman, A ^a   Launer, L J ^a,h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^e INSERM   (France)

^f UNIVERSITY OF NAVARRA   (Spain)

^g UNIVERSITY OF ZARAGOZA   (Spain)

^h NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; COHORT ANALYSIS; FAMILY HISTORY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SCREENING; SMOKING;

EID: 12144286492     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000115110.35610.80     Document Type: Article

References (28)

1. Graves AB, van Duijn CM, Chandra V, et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative reanalysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S48-S57.
2. Kihara T, Shimohama S, Urushitani M, et al. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res 1998;792:331-334.
3. Mihailescu S, Drucker-Colin R. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res 2000;31:131-144.
4. Shinton R, Beevers G. Meta-analysis of the relation between cigarette smoking and stroke. Br Med J 1989;298:789-794.
5. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups European Studies of Dementia. Neurology 1999;52:78-84.
6. Ott A, Slooter AJ, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840-1843.
7. Merchant C, Tang MX, Albert S, Manly J, Stern Y, Mayeux R. The influence of smoking on the risk of Alzheimer's disease. Neurology 1999;52:1408-1412.
8. Evans DA, Beckett LA, Albert MS, et al. Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol 1993;3:71-77.
9. Launer LJ, Feskens EJ, Kalmijn S, Kromhout D. Smoking, drinking, and thinking. The Zutphen Elderly Study. Am J Epidemiol 1996;143:219-227.
10. Galanis DJ, Petrovitch H, Launer LJ, Harris TB, Foley DJ, White LR. Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men. The Honolulu-Asia Aging Study. Am J Epidemiol 1997;145:507-515.
11. Launer LJ, Brayne C, Dartigues J-F, Hofman A. Studies on the incidence of dementia. Neuroepidemiology 1992;11(suppl 1):2-122.
12. Letenneur L, Commenges D, Dartigues J-F, Barberger-Gateau P. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol 1994;23:1256-1261.
13. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998;147:574-580.
14. Andersen K, Nielsen H, Lolk A, Andersen J, Becker I, Kragh-Sorensen P. Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study. Neurology 1999;52:85-90.
15. Copeland JR, McCracken CF, Dewey ME, et al. Undifferentiated dementia, Alzheimer's disease and vascular dementia: age- and gender-related incidence in Liverpool. The MRC-ALPHA Study. Br J Psychiatry 1999;175:433-438.
16. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-935.
18. Lord FM. A paradox in the interpretation of group comparisons. Psychol Bull 1967;68:304-305.
19. Van Duijn CM, Havekes LM, van Broeckhoven C, de Knijff P, Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. Br Med J 1995;310:627-631.
20. Rothman KJ, Greenland S, eds. Modern epidemiology. New York: Lippincott-Raven, 1998:41-115.
21. Jacqmin-Gadda H, Fabrigoule C, Commenges D, Dartigues JF. A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. Am J Epidemiol 1997;145:498-506.
22. Letenneur L, Dartigues JF, Commenges D, Barberger-Gateau P, Tessier JF, Orgogozo JM. Tobacco consumption and cognitive impairment in elderly people. A population-based study. Ann Epidemiol 1994;4:449-454.
23. Herbert LE, Scherr PA, Beckett LA, et al. Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of persons. Am J Epidemiol 1993;137:881-891.
24. Ford AB, Mefrouche Z, Friedland RP, Debanne SM. Smoking and cognitive impairment: a population-based study. J Am Geriatr Soc 1996;44:905-909.
25. Merchant C, Tang MX, Albert S, Manly J, Stern Y, Mayeux R. The influence of smoking on the risk of Alzheimer's disease. Neurology 1999;52:1408-1412.
26. Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use (1). N Engl J Med 1994;330:907-912.
27. Shinton R, Beevers G. Meta-analysis of the relation between cigarette smoking and stroke. Br Med J 1989;298:789-794.
28. Cruickshank JM, Neil-Dwyer G, Dorrance DE, Hayes Y, Patel S. Acute effects of smoking on blood pressure and cerebral blood flow. J Hum Hypertens 1989;3:443-449.